Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
58.6M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
65.9M
-
Shares change
-
+685K
-
Total reported value, excl. options
-
$3.63B
-
Value change
-
+$51.4M
-
Put/Call ratio
-
0.97
-
Number of buys
-
85
-
Number of sells
-
-88
-
Price
-
$55.11
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) as of Q2 2021
228 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock as of Q2 2021.
AGIOS PHARMACEUTICALS, INC. - Common Stock (AGIO) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.9M shares
.
Largest 10 shareholders include FMR LLC (8.08M shares), WELLINGTON MANAGEMENT GROUP LLP (6.77M shares), BlackRock Inc. (5.97M shares), VANGUARD GROUP INC (5.59M shares), JPMORGAN CHASE & CO (5.16M shares), Bellevue Group AG (4.35M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.98M shares), Rock Springs Capital Management LP (2.57M shares), Casdin Capital, LLC (2.17M shares), and STATE STREET CORP (1.97M shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.